Perrigo’s Next CEO Has Long OTC Brands History

Lockwood-Taylor Moves From Bayer As Perrigo Awaits Decision On OTC Oral Contraceptive

Patrick Lockwood-Taylor starts as president/CEO on 30 June, succeeding Murray Kessler as Perrigo awaits FDA decision on subsidiary HRA’s proposal for first US OTC sales of daily oral contraceptive. He’s moving from president of Bayer AG’s US business and regional president, consumer health North America.

• Source: Shutterstock

Perrigo Company PLC’s transition from leading the OTC drug private label/store brand space to also competing in branded consumer health product sales will be in the hands of an industry veteran with experience at two firms behind some of the most well-known global brands.

Perrigo firm on 8 June announced Patrick Lockwood-Taylor will start as president and CEO on 30 June, succeeding Murray Kessler...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Leadership

HI-Leadership (Premium-2): Melatonin, Omega 3 & Dietary Supplements: ADHD Hype or Help?

 
• By 

Two experts examine whether melatonin, omega-3, dietary supplements, vitamins, and minerals truly benefit adults with ADHD. While some supplements show promise in supporting brain health, scientific evidence for their effectiveness in improving ADHD symptoms remains limited.

Dermapharm Makes Changes To Turn Around Arkopharma’s Performance

 
• By 

Intensified competition in the dietary supplements market and consumers squeezed by cost-of-living pressures held back sales at Dermapharm's Arkopharma subsidiary in the first half. A leadership change, along with a renewed focus on commercial excellence, is hoped by Dermapharm to turn the business around.

‘Inside Regulatory Affairs’ With Kenvue's Kevin Whelan

This HBW Insight series profiles regulatory affairs specialists working in or supporting the consumer health and beauty product industries. In this installment, we speak to Kenvue's Kevin Whelan.

Estee Lauder Companies’ Freda To Exit In 2025 With Dreary Forecast For Fiscal New Year

 

The beauty giant expects organic sales growth for fiscal 2025 to range between -1% and 2%, falling well short of analyst consensus of 7.2%, reflecting the firm’s overexposure in China and Asia travel retail. A new CEO is incoming with Fabrizio Freda set to step down in June 2025.

More from HBW Insight

data

Type:DataArticle | Publication:HBW | Section:Health | Paywall:Premium — Article containing all Composer content for testing (Do not update)

 
• By 

To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.

Test: PDF Link Lifetime

Description description

headline test

description